RYTM · Rhythm Pharmaceuticals, Inc. · Investor Relations
$95.22
-0.50 (-0.52%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$6.79B
Shares
68.85M
Volume · Sep 30
737.18K
Avg daily vol (3M)
650.29K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-15 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-09-09 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-08-12 | Canaccord Genuity 46th Annual Growth Conference | Conference |
| 2026-08-04 | Rhythm Pharmaceuticals Q2 2026 Earnings Conference Call | Earnings call |
| 2026-06-13 | Results from Phase 2 Trial Evaluating Setmelanotide in PWS at Six Months | Event |
| 2026-05-05 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-16 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-26 | Q4 Earnings conference call (announced in 8-K) | Earnings call |